Kenneth George Klassen - Net Worth and Insider Trading
Kenneth George Klassen Net Worth
The estimated net worth of Kenneth George Klassen is at least $16 Million dollars as of 2024-09-24. Kenneth George Klassen is the Senior Officer of Knight Therapeutics Inc and owns about 2,725,000 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $16 Million. Details can be seen in Kenneth George Klassen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth George Klassen has not made any transactions after 2019-07-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth George Klassen
Kenneth George Klassen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth George Klassen owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Kenneth George Klassen’s form 4 insider trades.
Insider Ownership Summary of Kenneth George Klassen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-07-25 | Senior Officer |
Kenneth George Klassen Latest Holdings Summary
Kenneth George Klassen currently owns a total of 1 stock. Kenneth George Klassen owns 2,725,000 shares of Knight Therapeutics Inc (TSX:GUD) as of July 25, 2019, with a value of $16 Million.
Latest Holdings of Kenneth George Klassen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-07-25 | 2,725,000 | 5.91 | 16,104,750 |
Holding Weightings of Kenneth George Klassen
Kenneth George Klassen Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth George Klassen has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the acquisition of 2,725,000 shares on July 25, 2019, which cost Kenneth George Klassen around $20 Million.
Insider Trading History of Kenneth George Klassen
- 1
Kenneth George Klassen Trading Performance
GuruFocus tracks the stock performance after each of Kenneth George Klassen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth George Klassen is 13.29%. GuruFocus also compares Kenneth George Klassen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth George Klassen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kenneth George Klassen's insider trading performs compared to the benchmark.
Performance of Kenneth George Klassen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.09 | | | | | |
| Relative Return to S&P 500(%) | 8.3 | | | | | |
Kenneth George Klassen Ownership Network
Kenneth George Klassen Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Kenneth George Klassen is the Senior Officer of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Kenneth George Klassen made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Kenneth George Klassen Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth George Klassen. Currently GuruFocus does not have mailing address information for Kenneth George Klassen.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
